Completed OBSERVATIONAL NCT03616119

Gastroesophageal Reflux Disease in Azerbaijan

The Prevalence of Gastroesophageal Reflux Disease in Azerbaijan

Sponsor: Azerbaijan Medical University

Conditions Gastroesophageal Reflux Disease

Updated 7 times since 2018 Last updated: Dec 11, 2022 Started: Jan 1, 2018 Primary completion: Aug 1, 2019 Completion: Sep 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Gastroesophageal Reflux Disease and is currently completed. Azerbaijan Medical University leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Oct 2021 — Jan 2023 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting

▶ Show 2 earlier versions

Sep 2019 — Jan 2021 [monthly]

Active Not Recruiting
Sep 2018 — Sep 2019 [monthly]

Active Not Recruiting

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azerbaijan Medical University
Sevda Aghayeva

Data source: Azerbaijan Gastroenterology and Hepatology Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baku, Azerbaijan